In today's highly regulated and quality-driven healthcare environment, ensuring maximum patient safety and product quality is paramount. Our blood bag, featuring an advanced leukocyte reduction filter, is engineered to remove up to 99.9999% of donor white blood cells from blood products before storage. The result is a superior blood bag system that minimizes adverse transfusion reactions and enhances the overall quality of blood components.
Transfused blood products that contain residual white blood cells may be associated with several complications. These unwanted leukocytes can trigger febrile nonhemolytic transfusion reactions (FNHTRs), increase the risk of alloimmunization, and even transmit infections such as cytomegalovirus (CMV). By integrating a high-efficiency leukocyte reduction filter directly into the blood bag system, our technology ensures that each unit of blood not only meets but exceeds stringent safety standards.
Removal of donor white blood cells drastically reduces the risk of transfusion-related reactions. Patients experience fewer fevers and a lower incidence of antibody formation against donor antigens.
Studies have shown that blood components processed with leukocyte reduction filters contribute to decreased post-transfusion infection rates and a lowered risk of complications in immunocompromised patients.
Our system preserves the integrity of red blood cells (RBCs) and platelets, ensuring high recovery (>90% RBC recovery) and minimal volume loss (<30 ml). This means that each transfused unit is of the highest quality while still maintaining therapeutic effectiveness.
Although leukocyte reduction is an additional processing step, our advanced in-line filter minimizes additional costs. With our user-friendly design, the process is automatic and reliable, reducing overall wastage and ensuring economical use of resources.
Our integrated system is designed to seamlessly combine quality blood collection with state-of-the-art filtration:
The leukocyte reduction filter is built into the blood bag set, which allows immediate filtration after donation. This pre-storage reduction ensures that no harmful cytokines or leukocytes remain to compromise the product during storage.
Engineered with advanced polypropylene meltblown nonwoven material and enhanced with proprietary surface modification technology, our filter captures leukocytes efficiently while allowing vital blood components to pass through unimpeded.
Thanks to a clear, transparent filter housing and streamlined priming by gravity flow, medical professionals can monitor blood flow easily and have confidence that the reduction process is occurring as intended.
Quality control tests consistently verify that our device meets regulatory standards, ensuring that each blood bag delivers reliable and reproducible leukocyte reduction every time.
Our filters effectively remove leukocytes, a critical factor in preventing FNHTRs, alloimmunization, and CMV transmission.
With our innovative design, filtration times are reduced by approximately 30%, enhancing overall workflow efficiency.
With greater than 90% RBC recovery, our technology ensures that the maximum therapeutic benefit is maintained from every unit of donated blood.
Designed to lose less than 30 ml per unit, our blood bag system guarantees that essential blood components are preserved with minimal waste.
Our integrated system includes everything a blood collection center needs—from collection, storage, and processing to precise leukocyte reduction—thereby streamlining operations and reducing handling errors.
The clear filter housing allows for visual confirmation of prime status and flow, increasing confidence and reducing technical difficulties.
The blood bag system is compatible with existing collection and storage protocols, making it an ideal choice for hospitals, blood banks, and transfusion services looking to upgrade without overhauling current processes.
At the intersection of innovative design, regulatory compliance, and superior performance, our blood bag with an integrated leukocyte reduction filter is an industry leader. It is the go-to solution for any facility committed to excellence in transfusion medicine and a safer, more reliable blood supply.
Enhance safety and efficiency by ensuring that every unit of blood is leukoreduced before storage, reducing the incidence of transfusion reactions.
Streamline workflow with an all-in-one system that integrates seamlessly into your existing processes, offering high recovery rates and faster processing times.
Provide vulnerable patient populations with the safest blood products possible—minimizing complications and protecting immune function.
Invest in a safer, more efficient future in transfusion medicine with our advanced blood bag system featuring an integrated leukocyte reduction filter. Whether you are looking to reduce adverse reactions, streamline operations, or upgrade your blood collection technology, our solution stands out as the most reliable and innovative product on the market.
Contact Us Today
Reach out to our expert team to learn how our cutting-edge blood bag technology can be tailored to meet your facility's needs. Request a demo, speak with a product specialist, or download our detailed product brochure for more insights.
Copyright © Guangzhou DaJi Medical Science and Technology Co., Ltd. All Rights Reserved Sitemap | Powered by